Skip to content
Oncology Today with Dr Neil Love cover art

All Episodes

Oncology Today with Dr Neil Love — 523 episodes · page 1 of 6

#
Title
1

Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

2

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2

3

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

4

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

5

Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

6

Non-Small Cell Lung Cancer — Targeting KRAS G12C

7

Prostate Cancer — The Optimal Use of Hormonal Therapy

8

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

9

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

10

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

11

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

12

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

13

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal

14

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress

15

Metastatic Triple-Negative Breast Cancer — Patterns of Care

16

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

17

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

18

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

19

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress

20

HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

21

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

22

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

23

Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances

24

Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

25

Metastatic Bladder Cancer — Rapid Case Review Issue 6

26

For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress

27

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

28

Metastatic Bladder Cancer — Rapid Case Review Issue 5

29

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

30

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

31

Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies

32

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

33

Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting

34

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress

35

Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

36

Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

37

Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

38

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

39

For Oncology Nurses: Relapsed/Refractory Multiple Myeloma — Proceedings from the 2026 Annual ONS Congress

40

TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting

41

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3

42

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2

43

For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress

44

Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

45

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

46

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2

47

Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway

48

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress

49

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

50

EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

51

Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

52

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy

53

For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress

54

Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

55

HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review

56

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

57

Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer

58

Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft

59

Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer

60

Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

61

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

62

Endometrial Cancer — An Interview with Dr Floor J Backes

63

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

64

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay

65

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

66

Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

67

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

68

Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit

69

Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit

70

EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

71

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

72

Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances

73

Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit

74

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

75

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

76

Prostate Cancer — Fifth Annual National General Medical Oncology Summit

77

Colorectal Cancer — Fifth Annual National General Medical Oncology Summit

78

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

79

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

80

Ovarian Cancer — Fifth Annual National General Medical Oncology Summit

81

Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit

82

Multiple Myeloma — Fifth Annual National General Medical Oncology Summit

83

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck

84

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

85

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

86

Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit

87

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

88

Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit

89

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

90

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting

91

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

92

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

93

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

94

Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

95

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper

96

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances

97

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

98

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

99

Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer

100

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium